Drug interactions
Ado-trastuzumab + Dengue vaccine
Severity: Moderate
Ado-trastuzumab and Dengue vaccine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dengue vaccine is live attenuated, and cytotoxic therapy with ado-trastuzumab emtansine may impair the immune response and raise the risk of vaccine-related infection.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Ado-trastuzumab and Dengue vaccine interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Ado-trastuzumab
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
